CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices

Summary

This is a Phase 1b/IIa, single centre, non-randomised open-label uncontrolled study to assess safety, effect and PK of oral CRD-102 in patients with RHF associated with the presence of an LVAD.

Timeline

Start

2018-03-06

Primary completion

2018-10-10

Completion

2019-05-30

Drugs

Indications